Home
About
Overview
Sharing Data
ORCID
Help
History (21)
Comment on 'anti-adhesion therapies and the rule of 3 for rare events'.
Thyroidectomy for euthyroid patients with Hashimoto thyroiditis and persisting symptoms: A cost-effectiveness analysis.
Plants
Limited-sampling models for irinotecan pharmacokinetics-pharmacodynamics: prediction of biliary index and intestinal toxicity.
BRCA2 mutation and the risk of hematologic malignancy.
See All 21 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
BRCA2 mutation and the risk of hematologic malignancy.
BRCA2 mutation and the risk of hematologic malignancy. Leuk Lymphoma. 2006 Apr; 47(4):765-7.
View in:
PubMed
subject areas
Adult
Breast Neoplasms
Family Health
Female
Genes, BRCA2
Genetic Predisposition to Disease
Hematologic Neoplasms
Heterozygote
Humans
Leukemia, Promyelocytic, Acute
Middle Aged
Mutation
Neoplasms, Second Primary
Risk
authors with profiles
Olufunmilayo Olopade